PET scan images show that orally administered EPP6 accumulated in the intestines and made its way into the brain and bladder through blood circulation.
Hate needles? These researchers do too.
Researchers at UC Riverside are paving the way for diabetes and cancer patients to forget needles and injections, and instead take pills to manage their conditions.
Some drugs for these diseases dissolve in water, so transporting them through the intestines, which receive what we drink and eat, is not feasible. As a result, these drugs cannot be administered by mouth. However, UCR scientists have created a chemical “tag” that can be added to these drugs, allowing them to enter blood circulation via the intestines.
The details of how they found the tag, and demonstrations of its effectiveness, are described in a new Journal of the American Chemical Society paper.
The tag is composed of a small peptide, which is like a protein fragment. “Because they are relatively small molecules, you can chemically attach them to drugs, or other molecules of interest, and use them to deliver those drugs orally,” said Min Xue, UCR chemistry professor who led the research.
Xue’s laboratory was testing something unrelated when the researchers observed these peptides making their way into cells.
“We did not expect to find this peptide making its way into cells. It took us by surprise,” Xue said. “We always wanted to find this kind of chemical tag, and it finally happened serendipitously.”
This observation was unexpected, Xue said, because previously, the researchers believed that this type of delivery tag needed to carry positive charges to be accepted into the negatively charged cells. Their work with this neutral peptide tag, called EPP6, shows that belief was not accurate.
Testing the peptide’s ability to move through a body, the Xue group teamed up with Kai Chen’s group in the Keck School of Medicine at the University of Southern California and fed the peptide to mice. Using a PET scan — a technique similar to a whole-body X-ray that is available at USC, the team observed the peptide accumulating in the intestines, and documented its ultimate transfer into the animals’ organs via the blood.
Having proven the tag successfully navigated the circulatory systems through oral administration, the team now plans to demonstrate that the tag can do the same thing when attached to a selection of drugs. “Quite compelling preliminary results make us think we can push this further,” Xue said.
Many drugs, including insulin, must be injected. The researchers are hopeful their next set of experiments will change that, allowing them to add this tag to a wide variety of drugs and chemicals, changing the way those molecules move through the body.
“This discovery could lift a burden on people who are already burdened with illness,” Xue said.
Original Article: Injections for diabetes, cancer could become unnecessary
The Latest Updates from Bing News
Go deeper with Bing News on:
- Punjab: Fire Breaks Out In Chemical Factory In Mohali Injuring 5 Labourers
A chemical factory in the Industrial Focal Point at Chanalon in Punjab caught fire and injured five labourers. Two dozen fire tenders were rushed to the spot to control the blaze.
- PERSPECTIVE: Senate Must Act on Chemical Security Before Terrorists Do
DHS leadership recently underscored the importance of CFATS by noting that the agency was contacted a few years ago by a chemical manufacturer about an unusual order.
- OIG: FEMA Assisted Governments in Preparing to Respond to Radiological and Chemical Incidents
FEMA provided technical assistance, training, and program coordination, in conjunction with ongoing assessments and evaluations.
- Common Plastics Chemical Tied to Higher Odds for Postpartum Depression
Moms with higher prenatal levels of plastics chemicals known as phthalates may face a slightly increased risk of postpartum depression, according to a new study. Postpartum depression affects up to 20 ...
- Rebecca McPhail: Chemical industry needs fewer regulations (Opinion)
Manufacturers are receiving a mixed message from the Biden administration and its agencies, when it comes to American manufacturing. While President Joe Biden touts a pro-manufacturing agenda, chemica ...
Go deeper with Bing News on:
- Ocular Drug Delivery Technology Market Surging At A 8.4% CAGR To Cross US$ 39 Billion By 2032 X Herald
The ocular drug delivery technology market is anticipated to grow from US$ 16.4 billion in FY 2021 to US$ 17.74 billion in FY 2022. The industry saw
- Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device
Satio is pleased to announce a $3.5 million Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services.
- COVID Taught the Public About RNAi Drug Delivery, now the Market is Booming
Clinical trials utilizing RNAi drug delivery have surged, and BCC Research's new report "RNAi Drug Delivery: Technologies and Global Markets" predicts just how much the market will grow.
- Self-Administration: What Drug-Delivery Device Manufacturers Should Know
Up until now, most drug-delivery devices for injection have been designed for healthcare professionals as their primary users, but manufacturers will increasingly need to adjust their products to a new breed of clientele, including both patients and home ...
- Hydrogel Delivery Balances Tumor’s pH, Boosts Cancer Drug’s Activity
A new hydrogel-based delivery system balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of chemotherapeutic drug.